Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Relation Between the Initial Value of the Skeletal Mass Index and Pathological Response

NCT06151379 is registered in ClinicalTrials.gov with Acıbadem Atunizade Hospital as lead sponsor.

NCT NCT06151379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06151379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Relation Between the Initial Value of the Skeletal Mass Index and Pathological Response
Lead sponsor
Acıbadem Atunizade Hospital
Phase
Observational
Overall status
Completed
Start date
March 1, 2023
Completion date
October 20, 2023
Enrollment
69 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neoadjuvant chemotherapy